Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Reply: LATE to the PART-y.

Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Fardo DW, Flanagan ME, Halliday G, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murray ME, Nag S, Seeley WW, Sperling RA, White CL, Schneider JA.

Brain. 2019 Sep 1;142(9):e48. doi: 10.1093/brain/awz226. No abstract available.

PMID:
31359039
2.

In Vivo Assay of Cortical Microcircuitry in Frontotemporal Dementia: A Platform for Experimental Medicine Studies.

Shaw AD, Hughes LE, Moran R, Coyle-Gilchrist I, Rittman T, Rowe JB.

Cereb Cortex. 2019 Jun 19. pii: bhz024. doi: 10.1093/cercor/bhz024. [Epub ahead of print]

PMID:
31216360
3.

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA.

Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099. Erratum in: Brain. 2019 Jul 1;142(7):e37.

4.

Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration.

Lansdall CJ, Coyle-Gilchrist ITS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Robbins TW, Rowe JB.

Neurology. 2019 Apr 2;92(14):e1547-e1557. doi: 10.1212/WNL.0000000000007249. Epub 2019 Mar 6.

5.

Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.

Sami S, Williams N, Hughes LE, Cope TE, Rittman T, Coyle-Gilchrist ITS, Henson RN, Rowe JB.

Brain. 2018 Aug 1;141(8):2500-2510. doi: 10.1093/brain/awy180.

6.

White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes.

Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB.

Neurology. 2018 Mar 20;90(12):e1066-e1076. doi: 10.1212/WNL.0000000000005175. Epub 2018 Feb 16.

7.

Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.

Passamonti L, Luijten M, Ziauddeen H, Coyle-Gilchrist ITS, Rittman T, Brain SAE, Regenthal R, Franken IHA, Sahakian BJ, Bullmore ET, Robbins TW, Ersche KD.

Psychopharmacology (Berl). 2017 Aug;234(15):2289-2297. doi: 10.1007/s00213-017-4643-4. Epub 2017 May 27.

8.

Apathy and impulsivity in frontotemporal lobar degeneration syndromes.

Lansdall CJ, Coyle-Gilchrist ITS, Jones PS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Dick KM, Robbins TW, Rowe JB.

Brain. 2017 Jun 1;140(6):1792-1807. doi: 10.1093/brain/awx101.

9.

Managing cognition in progressive supranuclear palsy.

Rittman T, Coyle-Gilchrist IT, Rowe JB.

Neurodegener Dis Manag. 2016 Dec;6(6):499-508. Epub 2016 Nov 23. Review.

10.

Atomoxetine restores the response inhibition network in Parkinson's disease.

Rae CL, Nombela C, Rodríguez PV, Ye Z, Hughes LE, Jones PS, Ham T, Rittman T, Coyle-Gilchrist I, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Brain. 2016 Aug;139(Pt 8):2235-48. doi: 10.1093/brain/aww138. Epub 2016 Jun 24.

11.

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.

Coyle-Gilchrist IT, Dick KM, Patterson K, Vázquez Rodríquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB.

Neurology. 2016 May 3;86(18):1736-43. doi: 10.1212/WNL.0000000000002638. Epub 2016 Apr 1.

12.

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.

Ye Z, Rae CL, Nombela C, Ham T, Rittman T, Jones PS, Rodríguez PV, Coyle-Gilchrist I, Regenthal R, Altena E, Housden CR, Maxwell H, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Hum Brain Mapp. 2016 Mar;37(3):1026-37. doi: 10.1002/hbm.23087. Epub 2016 Jan 12.

13.

Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease.

Zhang J, Rittman T, Nombela C, Fois A, Coyle-Gilchrist I, Barker RA, Hughes LE, Rowe JB.

Brain. 2016 Jan;139(Pt 1):161-73. doi: 10.1093/brain/awv331. Epub 2015 Nov 18.

14.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, van Minkelen R, Rombouts SA, Cardoso MJ, Clegg S, Espak M, Mead S, Thomas DL, De Vita E, Masellis M, Black SE, Freedman M, Keren R, MacIntosh BJ, Rogaeva E, Tang-Wai D, Tartaglia MC, Laforce R Jr, Tagliavini F, Tiraboschi P, Redaelli V, Prioni S, Grisoli M, Borroni B, Padovani A, Galimberti D, Scarpini E, Arighi A, Fumagalli G, Rowe JB, Coyle-Gilchrist I, Graff C, Fallström M, Jelic V, Ståhlbom AK, Andersson C, Thonberg H, Lilius L, Frisoni GB, Pievani M, Bocchetta M, Benussi L, Ghidoni R, Finger E, Sorbi S, Nacmias B, Lombardi G, Polito C, Warren JD, Ourselin S, Fox NC, Rossor MN, Binetti G.

Lancet Neurol. 2015 Mar;14(3):253-62. doi: 10.1016/S1474-4422(14)70324-2. Epub 2015 Feb 4. Erratum in: Lancet Neurol. 2015 Dec;14(12):1151. Binetti, Giuliano [added].

15.

Research paper does not show causal link between benzodiazepine use and diagnosis of dementia.

Coyle-Gilchrist IT, Peck LF, Rowe JB.

BMJ. 2012 Nov 26;345:e7984; author reply e7993. doi: 10.1136/bmj.e7984. No abstract available.

PMID:
23183061
16.

Vasovagal ejaculation syncope.

Mozid AM, Coyle-Gilchrist IT, Mazhar SS.

Heart. 2009 Dec;95(23):1900. doi: 10.1136/hrt.2009.168765. No abstract available.

PMID:
19923330

Supplemental Content

Loading ...
Support Center